XNYS · Medical Care Facilities
Last stored close · Nov 10, 2026
Close · Nov 10, 2026
$504.42-0.09%
Model Target
available with Pro
Implied upside
vs the model target
Valuation methods
the methods behind the target
TickerWhale Score
—
Not scored in the latest run — the model needs every factor family, and one was unavailable for this name.
Score components
TickerWhale View
No narrated read for this name yet — the deterministic factors still carry the analysis.
What helps
- Technical
- Valuation
- Sentiment Signal
What to watch
- Quality & growth
Quality & growth
30%50Moderate
- Revenue growth 7.3%
- EPS growth 25.6%
Valuation
25%57Positive
- P/E 16.4
- EV/Sales 2.1
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.
#110 by market cap in our coverage · ~320,000 employees · Listed 2011-03-10 · www.hcahealthcare.com
Price history
Intraday to five-year windows are free with an account
Members switch between 1D, 1M, 6M, 1Y, 2Y and 5Y and see the live price. Signed out, this is the one-year stored series the technicals below are computed from.
Market intelligence
Peer position
Revenue growth (industry)Top 73%
P/E (industry)Cheaper than 73%
Technical analysis
our read · what classic indicators sayTickerWhale technical read
78/100Strong
Weighted composite of momentum, trend, relative strength, oscillators, volatility, drawdown and liquidity — not yet ranked against the universe in this run · 25% of the TickerWhale Score
Classic chart indicators
Strong Buy
6 buy · 0 sell · 2 neutral of 8 votes
TickerWhale reads HCA's technical setup as strong at 78/100, not yet ranked against the universe in this run. Classic chart indicators lean buy, pointing the same way.
Moving averages
9 / 9constructive
- vs 200-day+13.3%
- vs 50-day+12.8%
Momentum
Constructive
- RSI (14)65 · neutral
- Stochasticbuy
- CCIbuy
- Williams %Rneutral
Trend
Constructive
- ADX (14) trend strength26· trending
- MACD (12,26,9)buy(histogram 2.836)
How the classic verdict is reached
Moving averages (9) agree on buy — 9 buy vs 0 sell — and carry one vote between them.
Oscillators (7) vote individually: 5 buy · 0 sell · 2 neutral.
Result — 6 buy vs 0 sell of 8 votes = Strong Buy. Neutral votes never decide the verdict.
Fundamentals & valuation
2026-11-10 · revised_latestValuation multiples
- P/E (TTM)16.4
- P/S (TTM)1.4
- P/B—
- EV/EBITDA—
- EV/Sales2.1
- PEG0.64
Profitability & returns
- Gross margin—
- Net margin8.8%
- ROE—
- Debt/Equity—
Growth
- Revenue growth (YoY)7.3%
- EPS growth (YoY)25.6%
Green favourable · red stretched — multiples and D/E vs industry peers, margins and growth vs absolute thresholds.
Market capitalisation — $112.4B
Fundamentals history
Reported statement totals across recent periods.
| Metric | Dec '25 | Dec '24 | Dec '23 |
|---|---|---|---|
| Revenue | $75.6B | $70.6B | $65.0B |
| Gross profit | $31.4B | $28.7B | $25.6B |
| Operating income | $12.0B | $10.5B | $9.6B |
| Net income | $6.8B | $5.8B | $5.2B |
| EPS (diluted) | $28.33 | $22.00 | $18.97 |
| Free cash flow | $7.7B | $5.6B | $4.7B |
| Cash | $1.0B | $1.9B | $935M |
| Total debt | $48.3B | $44.9B | $41.5B |
| Equity | -$6.0B | -$2.5B | -$1.8B |
| Net debt | $47.3B | $43.0B | $40.6B |
| Debt / equity | -8.02 | -17.96 | -23.39 |
| Liabilities / assets | 1.05 | 0.99 | 0.98 |
Fundamentals are stored revised/latest (ADR-009): each period reflects the most recent vendor refresh, NOT point-in-time as-reported values. Do not use this series to claim what was known on a past date.
Model Target
Model Target is a Pro feature
Scores, factors and technicals stay free. The model's price target is part of TickerWhale Pro.
The Model Target is a TickerWhale Pro feature
A target exists for this name — the model priced it in the latest nightly run. Pro members see the target, its range and the methods behind it; one name's target is free every trading day.
Or see the current free one: KNSA →
Peers
| Company | Score | Pulse | P/E | P/E fwd | P/B | EV/Sales | Price | Chg | Estimate | Upside | Rev. gr. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HCACurrentHCA Healthcare | — | 78 | 16.4 | — | — | 2.1 | $504.42 | -0.09% | +7.3% | ||
| EXELExelixis | 82 | 88 | 21.3 | — | 9.9 | 7.4 | $70.58 | -1.62% | +9.2% | ||
| KNSAKiniksa Pharmaceuticals International plc. - | 79 | 81 | 98.2 | — | 12.1 | 9.3 | $95.02 | -3.79% | +58.9% | ||
| THCTenet Healthcare | 79 | 81 | 10.9 | — | 5.2 | 1.6 | $290.27 | +0.44% | +7.5% | ||
| INCYIncyte | 76 | 67 | 15.5 | — | 3.9 | 3.6 | $120.30 | -1.30% | +26.9% | ||
| LIVNLivaNova | 76 | 84 | 27.2 | — | 3.9 | 3.3 | $91.14 | -1.59% | +12.4% |
News, sentiment, the Street view and Ask Willy are free with an account
A free account shows the stories attached to this name, the Sentiment Signal breakdown, analyst consensus, the options read and the AI narration of the model output.